Skip to main content

Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes.

Perret-Liaudet A, Pelpel M, Tholance Y, Dumont B, Vanderstichele H, Zorzi W, Elmoualij B, Schraen S, Moreaud O, Gabelle A, Thouvenot E, Thomas-Anterion C, Touchon J, Krolak-Salmon P, Kovacs GG, Coudreuse A, Quadrio I, Lehmann S

Publication: J Alzheimers Dis (2012) • Vol 31 • Page 13-20PMID: 22495345View on PubMed

Purpose

This paper investigated collection tube choice as a source of pre-analytical variability in the quantification of several biomarkers of Alzheimer's Disease (AD) in cerebrospinal fluid (CSF).

Conclusion

Sampling tubes made of polypropylene (PP), polystyrene (PS), or a polypropylene and polyethylene (PP-PE) copolymer yielded significant differences in the concentrations of each of the three AD biomarkers investigated in CSF. Effects were dependent on the biomarker quantified; for example, the concentration of amyloid-beta peptides (AB) displayed the greatest variation between tube types (-48%/+31%) while phosphorylated Tau (p-Tau181P) displayed the lowest variation. Accordingly, the authors postulate that quantification of AB peptides in CSF, but not other markers, carries a risk of misdiagnosis for AD. An analysis of tube composition determined that effects could not be linked to composite material. Post-collection storage of CSF specimens in new tubes for up to 24 hours at 2-8 degrees C prior to freezing did not alter effects compared to specimens stored at room temperature for 15 min. An artificial increase in protein content abolished tube-dependent effects, leading the authors to postulate that CSF specimens with low protein content are particularly susceptible to potential biomarker adsorption to the surface of the tube.

Studies (2)

Purpose

The purpose of this study was to investigate the chemical composition of collection tubes as a source of pre-analytical variability of three biomarkers of AD in CSF (AB; total tau protein, hTau; p-Tau181P). CSF specimens (2 ml) were collected from 12 patients by lumbar puncture directly into 4 different commercial tubes made of either polypropylene (PP) (Sarstedt 10 ml, Becton Dickinson 15 ml) or polystyrene (PS) (Fisher Scientific hemolysis tube 5 ml, Becton Dickinson 14 ml). CSF specimens were then stored on ice, centrifuged, aliquoted, and stored at -80 degrees C for less than 6 months before analysis.

Summary of Findings

AB40 and AB42 concentrations differed significantly among all four types of collection tubes examined (p<0.05), with the highest concentrations observed in CSF specimens collected into polypropylene tubes from Sarstedt followed by Fisher Scientific's hemolysis polystyrene were also present, with significantly lower concentrations among CSF specimens collected in polystyrene tubes from Becton Dickinson compared to either brand of polypropylene tubes. For p-Tau181P, significant differences in concentration was limited to CSF specimens collected into Fisher Scientific's hemolysis polystyrene tubes compared to other tube types (p<0.05). The authors note that the magnitude of variation attributable to tube type carries a potential risk for AD misdiagnosis for AB40 and AB42, but not other markers.
  • Biospecimens

    FluidCerebrospinal Fluid
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
  • Platforms

    PeptideELISA
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    Becton Dickinson 14 ml tube (PS)
    Becton Dickinson 15 ml tube (PP)
    Fisher Scientific hemolysis tube 5 ml (PS)
    Sarstedt 10 ml tube (PP)
    ELISA SpecificTargeted peptide/protein
    AB40
    AB42
    hTau
    p-Tau181P